Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various aspects of their respective microbial biologic development programs.


To order this 320+ page report, which features 150+ figures and 150+ tables, please visit this – https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html


The USD 9.3 billion (by 2030) financial opportunity within the microbial biomanufacturing market has been analyzed across the following segments:

Type of Product



Type of Biologic

  • Proteins
  • Enzymes
  • Growth Hormones
  • Antibody based Drugs
  • Others (plasmid DNA, probiotics, microbiome-based biologics)
  • Type of Microbial Expression System
  • Bacteria
  • Yeast
  • Others (Algae and fungi)

Scale of Operation


Preclinical / Clinical

Type of End User

Small Companies

Mid-sized Companies

Large / Very Large Companies

Key Geographical Regions

North America


Asia Pacific

Middle East and North Africa

Latin America

The Microbial Contract Biomanufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

  • AGC Biologics
  • Aldevron
  • BioVectra
  • EirGenix
  • Etinpro
  • Eurogentec
  • Northway Biotechpharma
  • Ology Bioservices
  • Porton Biopharma
  • Stelis Biopharma


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Competitiveness Analysis


6. Company Profiles 

7. Recent Partnerships 

8.  Recent Expansions 

9.  Microbial fermentation technology platforms

10. Assessment of Relative Competition and Growth 

11. Make versus Buy Decision Making Framework 


12.  Big Pharma Initiatives in Microbial Biomanufacturing


13. Case study: comparison of small molecule and large 


14. Market Sizing and Opportunity Analysis

15. Impact of covid-19 pandemic on microbial contract biomanufacturing market

16. Swot Analysis 

17. Conclusion Appendix 3: List of Companies and Organizations

18. Interview Transcripts


19. Appendix 1: Tabulated Data


20. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415



Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe